Navigation Links
Strategic Diagnostics Appoints Kevin J. Bratton as Chief Financial Officer
Date:5/26/2009

the Company produces unique, sophisticated reagents, reagent systems, antibody design services and biodetection solutions to customer needs. Customers benefit from the enablement of their research into critical health care challenges of disease understanding, therapeutic development and diagnostic discovery. Industrial customers benefit with quantifiable "return on investment" by reducing time, labor, and/or material costs. All this is accomplished while increasing accuracy, reliability and actionability of essential test results. The Company is focused on sustaining this competitive advantage by leveraging its expertise in antibody design, immunology, proteomics, bio-luminescence and other bio-reactive technologies to continue its successful customer-focused research and development efforts. Recent innovations in high throughput production of antibodies from genetic antigens will complement the Company's established leadership in commercial and custom antibody production for the Research, Human/Animal Diagnostics, and Pharmaceutical industries, and position the Company for broader participation in proteomics research and discovery.

This news release contains forward-looking statements reflecting SDI's current expectations. When used in this press release, the words "anticipate", "could", "enable", "estimate", "intend", "expect", "believe", "potential", "will", "should", "project" "plan" and similar expressions as they relate to SDI are intended to identify said forward-looking statements. Investors are cautioned that all forward-looking statements involve risks and uncertainties, which may cause actual results to differ from those anticipated by SDI at this time. Such risks and uncertainties include, without limitation, changes in demand for products, delays in product development, delays in market acceptance of new products, retention of customers and employees, adequate supply of raw materials, the successful integration and consolidation of
'/>"/>

SOURCE Strategic Diagnostics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Sonitus Medical Secures Strategic Investment and Technology Advancement Agreement From In-Q-Tel
2. Aflac Incorporated to Present at the Sanford Bernstein 25th Annual Strategic Decisions Conference
3. Medco CEO to Present at the Sanford C. Bernstein & Co. LLC 25th Annual Strategic Decision Conference 2009
4. Arcadia Resources Announces Sale of Non-Strategic Businesses
5. NxStage Announces Strategic Business Alliance with Asahi Kasei Kuraray Medical
6. The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure
7. MEI Development Corporation and GE Healthcare Sign Strategic Agreement
8. GSK Extends Strategic Collaboration with Aspen
9. Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services
10. Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
11. Noblis Insights Panel Finds Growing Interest in Hospital Affiliation as a Strategic Response to Challenging Market Conditions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...rsity researchers, from the School of Medicine,s D...ic pathways by which products of lipid peroxidatio..., are metabolized. The pathways were identified by... analysis. The findings shed new light on the mech...butyrate, also known as "the date rape drug." The ...
(Date:12/4/2009)...ure done immediately or 3 weeks later, study shows...Timing of surgical repair or reconstruction of mul...t outcome, a new study has found. , Multiple-li...slocations that can occur in high-impact car crash...rm surgery to repair these injuries hasn,t been de...
(Date:12/4/2009)...r Applauds Historic Effort but Points out Potentia...n Final Health Care Reform ,, NEW YORK, Dec. ...rnal of Medicine today published a Perspective o...hored by Irwin Redlener, M.D., president, Children...isaster Preparedness and Professor of Clinical Pop...
(Date:12/4/2009)...through hookah, research shows , , FRIDA...afer than cigarettes for smoking tobacco, research...oke tobacco with a water pipe inhale carbon monoxi... disease and nicotine addiction. , The study in...bacco using a water pipe and a single cigarette. A...
(Date:12/4/2009)... Dec. 4 When the spread ...epartment of Health Services needed to get more in...fore. Join Sonic Foundry, Inc. (Nasdaq: SOFO ),...sting and knowledge management, for a live webinar... of Health Services, will share how in-house webca...
Breaking Medicine News(10 mins):Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:Water Pipes No Safer Than Cigarettes 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3
...s Corp. (Nasdaq:,HMSY) today announced that it wil...onference, which will be held January 7-10, 2008 a...: http://www.newscom.com/cgi-bin/prnh/20030304/NY...ast of the Company,s presentation can be accessed ...
...nix,Pharmaceuticals, Inc. (Nasdaq: IDIX ) announc...porate overview, including an update of the compan..., at the upcoming JP Morgan 26th,Annual Healthcare...entation can be accessed,under "Calendar of Events...
...am for Lead Product, MENLO PARK, Calif., Dec. 20 ...t it has completed a private placement financing,r...opment of the company,s,novel antiplatelet therapy...on,from Prospect Venture Partners, Ridgeback Capit...
...-Opportunities program of Agriculture and ..., ON, Dec. 20 /PRNewswire-FirstCall/ - Bioniche Li...hnology-driven Canadian,biopharmaceutical company,... Ontario. The $5 million repayable,contribution ha...
..., 2007 Wiley-Blackwell, the scientific, technical...n Wiley & Sons, Inc (NYSE: JWa), (NYSE: JWb), and ...anisation dedicated to improving healthcare decisi...World Banks list of low-income economies (countrie...
...dds, study found , THURSDAY, Dec. 20 (HealthDay Ne...cy can boost a child,s risk of developing allergie...nska Institute, Stockholm, analyzed questionnaires...s, 2 years and 4 years. In addition, the researche...
Other Medicine News:Health News:Cogentus Pharmaceuticals Completes $62.5 Million Private Financing 2Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 2Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 3Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 4Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 5Health News:Low-income countries now have free, one-click access to Cochrane Library 2Health News:Parents' Smoking Boosts Child's Allergy Risk 2
(Date:12/4/2009)...ec. 4 Bayer Diabetes Care today an...Express Your Simple Win Creativity Contest." Nick ... video entries submitted by children with diabetes...-person meeting today with Nick. ,, The winne..., age 6, from Danbury, CT, who dreams of becoming ...
(Date:12/4/2009).... 4 AstraZeneca (NYSE: ...dministration (FDA) has approved once-daily SEROQU... Tablets as adjunctive (add-on) treatment to antid...r (MDD). SEROQUEL XR is the only medication in its...ressive disorder as adjunctive therapy and acute d...
(Date:12/3/2009)... Allen Medical Systems, ...RC ), today announced the launch of its new Allen ...business website www.AllenAmatech.com . ,, ... identity and includes an online version of the ne...design specifications for the products. "We hope t...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Male seahorses like big mates 9136 1Male seahorses like big mates 9136 2Hormone clue to root growth 9134 1Hormone clue to root growth 9134 2Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 1Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 2Journal of Vascular and Interventional Radiology 3A New patient radiation safety guidelines 9132 3
...e 14, 2007) - Ambrilia,Biopharma Inc. (TSX:AMB), a...molecules and peptides to treat infectious disease...Meeting today, during,which the data reported yest...ors and recent developments were highlighted. The,...rd, Mr. Frederic,Porte, and a progress report was ...
...ire/ -- Results of the,Option (TOcilizumab Pivotal...l, the first multinational Phase III study outside...ra (either 4mg/kg,or 8mg/kg) plus methotrexate ach...vement in the signs and symptoms of moderate to,se...s treated with,placebo and methotrexate, a current...
Other Medicine Technology:Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 2Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 3Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 2Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 3Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 4Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid,Arthritis Compared to a Current Standard of Care 5
Pediatric Perfect Fit Tracheostomy Collar™
Portex® ULTRAperc® Percutaneous DilationTracheostomy Kits with Blue Line ULTRA® Tube
D.I.C.® Tracheostomy Care Trays
4691 TC Trach Care Tray
Medicine Products: